Infliximab for the Treatment of Severe Steroid Refractory Acute Graft-versus-host Disease in Three Patients after Allogeneic Hematopoietic Transplantation

Takahisa Yamane Department of Clinical Hematology and Clinical Diagnostics, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8586, Japan

Ryousuke Yamamura Department of Clinical Hematology and Clinical Diagnostics, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8586, Japan

Yasutaka Aoyama Department of Clinical Hematology and Clinical Diagnostics, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8586, Japan

Hirohisa Nakamae Department of Clinical Hematology and Clinical Diagnostics, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8586, Japan

Taro Hasegawa Department of Clinical Hematology and Clinical Diagnostics, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8586, Japan

Chikahiko Sakamoto Department of Clinical Hematology and Clinical Diagnostics, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8586, Japan

Hisako Shibata Department of Clinical Hematology and Clinical Diagnostics, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8586, Japan

Yoshiki Terada Department of Clinical Hematology and Clinical Diagnostics, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8586, Japan

Genju Koh Department of Clinical Hematology and Clinical Diagnostics, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8586, Japan

Mayasuki Hino Department of Clinical Hematology and Clinical Diagnostics, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8586, Japan

show all

References

Scallon, B.J., Moore, M.A., Trinh, H., Knight, D.M. and Glirayeb, S. (1995) "Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions", Cytokine 7, 251–259.
PubMed Web of Science ®Google Scholar
Present, D.H., Rutgeerts, P., Targan, S., Hanauer, S.B., Mayer, L., van Hogezand, R.A., Podolsky, D.K., Sands, B.E., Braaktnan, T., DeWoody, K.L., Schaible, T.F. and van Deventer, S.J. (1999) "Infliximab for the treatment of fistulas in patients with Crohn's disease", N. EngL J. Med. 340, 1398–1405.
PubMed Web of Science ®Google Scholar
Choi, H.K., Seeger, J.D. and Kuntz, K.M. (2000) "A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis", Arthritis Rheum. 43, 2316–2327.
PubMed Web of Science ®Google Scholar
Kobbe, G., Schneider, P., Rohr, U., Fenk, R., Neumann, F., Aivado, M., Dietze, L., ICronenwett, R., Hunerliturkoglu, A. and Haas, R. (2000 "Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody", Bone Marrow Transplant. 28, 47–49.
Web of Science ®Google Scholar
Couriel, D.R., Hicks, K., Giralt, S. and Champlin, R.E. (2000) "Role of tumor necrosis factor-alpha inhibition with iiillixiMAB in cancer therapy and hematopoietic stem cell transplantation", Curr. Opin. OncoL 12, 582–587.
PubMed Web of Science ®Google Scholar
Knight, D.M., Trinh, H., Le, J., Siegel, S., Shealy, D., McDonough, M., Scallon, B., Moore. M.A., Vilcek, J. and Daddona, P. (1993) "Construction and initial characterization of a mouse-human chimeric anti-TNF antibody", Mol. Immunol. 30, 1443–1453.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Infliximab for the Treatment of Severe Steroid Refractory Acute Graft-versus-host Disease in Three Patients after Allogeneic Hematopoietic Transplantation

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Infliximab for the Treatment of Severe Steroid Refractory Acute Graft-versus-host Disease in Three Patients after Allogeneic Hematopoietic Transplantation

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date